I have been at the Cancer Institute of New Jersey since 2004, after completing a fellowship at Mount Sinai School of Medicine, which was preceded by a residency at Montefiore Medical Center of Albert Einstein College of Medicine.
Working closely with experts across multi-disciplines in the Prostate Cancer Program and the Urologic Oncology Program, including radiation and surgical oncologists, nurses and social workers, I provide patients with a comprehensive evaluation and help educate them about their disease so that they can make informed decisions about their treatment options.
Some of these options may include clinical trials. As a member of the Phase I/Investigational Therapeutics Program, I have the opportunity to conduct research on new drugs and compounds to see how they impact current cancer treatments and see if they can be applied toward new therapies. While I have clinical expertise in prostate, kidney, bladder and testis cancers, my research interest is in investigational drugs and how they affect all solid tumors.
I am the author or co-author of more than 20 publications and serve on the editorial board of HemOnc Today. As a member of the Eastern Cooperative Oncology Group, Genitourinary Committee and Prostate Cancer Clinical Trial Consortium I help develop clinical trials with novel agents and answer clinical trials in prostate cancer on a national level.
Prostate cancer, kidney cancer, bladder cancer and testis cancers, Phase I clinical trials
- Robert DiPaola Research Award, Cancer Institute of New Jersey Prostate Cancer Center, 2008
- Arnold P. Gold Foundation, Gold DOC recognition, 2012
To schedule a new patient appointment call 732-235-8515.
For all other inquiries call 732-235-2465.